https://www.pro.novartis.com/br-pt/ 2026-03-17T18:50:04+00:00 daily 1.0 https://www.pro.novartis.com/br-pt/artigos/cosentyx/desvendando-fisiopatologia-da-hidradenite-supurativa 2026-01-22T13:30:00+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/video-pilulas-sobre-duvidas-do-tratamento-com-jakavir 2025-11-11T12:34:40+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/entresto/beneficio-de-iniciar-o-tratamento-de-icfer-com-entrestor-vantagens-da-troca-de-iecabra-para-inra3 2026-02-13T13:35:05+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/estudos-sunshine-e-sunrise-comprovam-eficacia-de-cosentyx-secuquinumabe-no-tratamento-da 2026-01-28T18:47:55+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/sybrava/video-guia-mostra-como-aplicar-sybrava-medicos-habilitados 2026-01-28T19:14:22+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/entresto/um-olhar-alem-da-sobrevida-no-tratamento-da-ic-priorizando-qualidade-de-vida 2026-02-13T13:36:40+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/conheca-solucao-digital-que-facilita-o-cotidiano-da-clinica-e-ajuda-os-pacientes-encontrarem 2026-01-22T18:14:04+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/sybrava/inclisirana-no-estudo-victorion-initiate3 2026-01-26T12:37:35+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/entresto/o-papel-da-educacao-do-paciente-na-adesao-medicamentosa-e-controle-da-insuficiencia-cardiaca 2026-02-13T13:39:00+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/desafios-e-estrategias-no-diagnostico-da-insuficiencia-cardiaca-com-fracao-de-ejecao-preservada-no 2025-11-05T13:10:20+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/sybrava/estudo-orion-11-inclisirana-em-pacientes-com-doenca-cardiovascular-aterosclerotica-dcva-ou-um-risco 2026-01-26T12:26:40+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/entresto/alem-dos-sintomas-biomarcadores-na-avaliacao-e-manejo-da-insuficiencia-cardiaca 2026-02-13T13:28:12+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/importancia-do-estadiamento-da-doenca-no-diagnostico-e-tratamento-da-hs 2026-01-22T13:25:23+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/sybrava/inclisirana-no-manejo-de-pacientes-com-historico-de-ldl-c-elevado-e-iam 2026-03-31T17:58:43+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/sustentabilidade-e-resposta-mantida-longo-prazo-na-psoriase-em-placas-moderada-grave-possivel-com 2026-01-22T12:27:56+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/sybrava/estudo-orion-10-inclisirana-em-pacientes-com-ldl-colesterol-elevado 2026-01-26T12:16:45+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/cosentyx-secuquinumabe-resultados-na-pele-e-na-qualidade-de-vida 2026-01-28T18:48:45+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/sybrava/estudo-orion-9-inclisirana-para-o-tratamento-da-hipercolesterolemia-familiar-heterozigotica-hfhe 2026-01-26T12:20:23+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/psoriase-do-couro-cabeludo-e-os-resultados-do-tratamento-com-cosentyx-secuquinumabe 2026-01-28T18:49:32+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/o-burden-da-hidradenite-supurativa-na-vida-do-paciente-implicacoes-do-diagnostico-tardio 2026-01-22T19:11:56+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/jornada-do-paciente-com-psoriase 2026-01-22T19:22:50+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/exames-previos-para-o-tratamento-com-imunobiologicos-em-paciente-com-psoriase 2026-01-22T19:23:30+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/vacinacao-no-paciente-com-psoriase-submetido-tratamento-com-imunobiologicos 2026-01-22T19:27:49+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/guia-de-solicitacao-de-cosentyx-secuquinumabe-para-psoriase-no-sistema-de-saude-suplementar-e-no 2026-01-28T18:50:19+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/entresto/importancia-da-rapida-otimizacao-do-tratamento-da-insuficiencia-cardiaca-orientado-por-diretrizes1 2026-01-28T14:29:47+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/dr-renato-centrone-faz-apresentacao-de-seu-caso-clinico-scemblix-no-brasil 2026-01-16T17:07:03+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/medicamentos/oncologia/kisqali/kisqali-na-qualidade-de-vida-e-sobrevida-das-pacientes-caso-clinico 2026-01-28T18:27:06+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/dr-fabio-pires-faz-apresentacao-de-seu-caso-clinico-scemblix-no-brasil 2026-01-16T17:07:41+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/jakavi-nao-trata-apenas-de-sintomas-e-tamanho-do-baco-dr-renato-tavares 2026-01-16T16:45:28+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kesimpta/atualizacao-dos-novos-criterios-de-diagnostico-de-esclerose-multipla-em-criterios-de-mcdonald 2026-01-19T18:36:00+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/sobrevida-global-no-tratamento-da-mielofibrose 2026-01-16T16:43:58+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/dr-renato-centrone-faz-abertura-do-evento-scemblix-no-brasil-necessidades-nao-atendidas-em-linhas 2026-01-16T17:04:34+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kesimpta/terapias-anti-cd20-sao-mesmas-sim-ou-nao-dr-andres-barboza-arg 2026-01-19T18:40:34+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/jakavi/sobrevida-global-no-tratamento-da-mielofibrose-subgrupo-int-1 2026-01-28T12:38:27+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/cosentyx/o-atraso-no-diagnostico-como-uma-falha-fundamental-na-hs 2026-01-22T13:22:04+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kisqali/medicamentos/oncologia/kisqali/tratamento-do-cancer-de-mama-metastatico-luminal-em-populacoes 2026-01-19T19:48:22+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/medicamentos/neurologia/kesimpta/kesimpta-experience-justificativa-para-intervencao-precoce-com 2025-11-07T13:06:46+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/teaser-dr-andre-feldman-qualidade-de-vida-na-ic 2025-11-07T12:57:56+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/dr-renato-centrone-na-abertura-do-evento-scemblix-no-brasil-resultados-de-seguranca-do-estudo-e 2026-01-16T17:05:18+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/jakavi/video-com-o-dr-martin-griesshammer-alemanha-sobre-o-tratamento-da-policitemia-vera 2026-01-28T12:48:01+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/sybrava/video-guia-como-aplicar-sybrava-para-medicos-dr-bruno-mioto 2026-01-28T19:18:06+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kesimpta/saude-cerebral-dr-rodrigo-kleinpaul 2026-01-19T18:41:41+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/xolair/guia-de-solicitacao-de-xolair-omalizumabe-para-tratamento-de-asma-alergica-grave-no-sistema-de 2026-01-28T19:06:52+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/cosentyx/diagnostico-autorrelatado-em-hs 2026-01-22T13:24:08+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kisqali/tratamento-com-kisqali-em-pacientes-idosas-atualizacao-pos-congresso-internacional 2026-01-19T19:45:51+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/anemia-ao-tratamento-e-transitoria-e-manejavel-dr-renato-centrone 2026-01-16T16:47:32+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kesimpta/biomarcadores-snfl-eye-tracker-no-manejo-da-esclerose-multipla-dr-mark-freedman-can 2026-01-19T18:44:11+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/uso-dos-questionarios-de-sintomas-no-tratamento-da-mielofibrose-dra-cristiana-solza-e-dra-claire 2026-01-16T16:52:52+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kesimpta/experiencias-no-tratamento-da-esclerose-multipla-com-kesimpta-dr-herval-ribeiro-soares 2026-01-28T14:49:45+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/medicamentos/oncologia/kisqali/caso-clinico-kisqali-ribociclibe-no-tratamento-de-pacientes-na-pre 2025-11-25T19:10:39+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/uso-de-jakavir-mesmo-sem-mutacao-em-jak-dr-renato-centrone 2026-01-16T16:48:52+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kesimpta/o-papel-dos-biomarcadores-e-sua-contribucao-no-acompanhamento-da-esclerose-multipla-dr-herval 2026-01-19T18:47:18+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/medicamentos/oncologia/kisqali/caso-clinico-kisqali-ribociclibe-no-tratamento-de-pacientes-na-pos 2025-11-04T17:17:05+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/paciente-com-risco-intermediario-ou-alto-incluindo-com-ipss-int-1-dra-thiana-marinho 2026-01-16T16:46:25+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/scemblix/expert-talks-falha-na-terapia-e-necessidades-nao-atendidas-em-pacientes-cp-cml-dr-michael-j-mauro 2026-02-10T14:28:42+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/video-depoimentos-de-pacientes-vale-mais-saude 2025-11-10T13:19:42+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/jakavi/beneficios-do-tratamento-precoce-da-mielofibrose-dr-prithviraj-bose 2026-01-28T13:05:10+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/sybrava/experiencia-inicial-com-uso-de-sybrava-em-paciente-com-risco-cardiovascular-muito-alto-caso 2026-01-28T19:22:08+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/scemblix/expert-talks-principios-no-tratamento-da-lmc-dr-michael-j-mauro-eua 2026-02-10T18:12:14+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/entresto/teaser-dra-lidia-z-moura-beneficios-do-quarteto-fantastico 2026-02-10T18:32:13+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/hidradenite-supurativa-hs-e-ultrassonografia-usg 2026-01-22T19:47:50+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/psoriase-em-placas-palmoplantar-e-os-resultados-do-tratamento-com-cosentyx-secuquinumabe 2026-01-28T18:51:10+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/avaliacao-da-gravidade-da-hidradenite-supurativa-como-classificar-e-monitorar 2026-01-22T19:35:39+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/estudo-ivepsa-secuquinumabe-no-tratamento-da-psoriase-com-risco-de-artrite-psoriasica 2026-01-22T19:32:10+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/xolair/highlights-simposio-congresso-brasileiro-de-dermatologia-dr-gleison-duarte 2026-01-23T13:51:10+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/asma-alergica-grave-relembrando-conceitos-importantes 2025-11-11T12:16:50+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/xolair/eficacia-e-seguranca-comprovadas-em-pacientes-com-asma-alergica-moderada-e-grave-desde-2004 2026-01-23T13:32:06+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/xolair/diagnostico-diferencial-da-uce 2026-01-23T13:39:29+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/xolair/tratamento-imunobiologico-na-asma-alergica-grave-diferenciacao-da-molecula-omalizumabe 2026-01-23T13:41:24+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/impacto-da-psoriase-de-moderada-grave-na-qualidade-de-vida-e-na-expectativa-do-ponto-de-vista-do 2026-01-22T19:37:14+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/impacto-da-psoriase-de-moderada-grave-na-pele-e-alem-da-pele 2026-01-22T19:41:47+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/psoriase-atualizacao-sobre-mecanismos-fisiopatologicos-e-o-papel-da-il-17-no-prurido 2026-01-22T19:47:05+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kesimpta/progressao-na-pratica-clinica-da-esclerose-multipla-em-como-avaliar-dr-mateus-boaventura 2026-01-19T18:48:20+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kesimpta/passo-passo-da-aplicacao-de-kesimpta-com-caneta-sensoready 2026-01-28T17:09:50+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kesimpta/aula-evento-mscience-woman-esclerose-multipla-e-endocrinologia-efeitos-metabolicos-no-controle-da 2026-01-19T18:52:50+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kesimpta/aula-evento-mscience-woman-sexual-health-and-fertility-woman-ms-dra-jiwon-oh-can 2026-01-19T18:54:31+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kesimpta/aula-evento-mscience-woman-o-papel-da-nutricao-na-atividade-inflamatoria-da-em-dra-marcela-mendes 2026-01-19T18:55:51+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kesimpta/terapias-modificadoras-de-doencas-de-alta-eficacia-em-em-ms-evo-mark-dr-mark-freedman-can 2026-01-19T18:57:07+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kesimpta/aula-evento-mscience-woman-overview-pregnancy-ms-family-planning-dra-jiwon-oh-can 2026-01-19T19:01:42+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kesimpta/kesimpta-ofatumumabe-mecanismo-de-acao-ligacao-celulas-b 2026-01-19T19:04:25+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kesimpta/aula-evento-bctrims-evolucao-do-tratamento-dra-juliana-santiago 2026-01-19T19:06:24+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kesimpta/aula-evento-bctrims-confianca-no-tratamento-da-em-recorrente-pratica-e-resultados-de-longo-prazo 2026-01-19T19:08:01+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/kesimpta/guia-completo-para-sua-pratica-clinica-sobre-esclerose-multipla-e-kesimpta-ofatumumabe 2026-01-28T17:10:42+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/kesimpta/inicio-precoce-com-alta-eficacia-em-emr-paciente-naive-em-uso-de-kesimpta-ofatumumabe 2026-01-28T17:13:16+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/kesimpta/kesimpta-eficacia-apos-falhas-terapeuticas-previas-um-novo-olhar-para-pacientes-com-emr 2026-01-28T17:17:05+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/kesimpta/caso-clinico-kesimpta-como-alternativa-eficaz-para-pacientes-em-falha-de-natalizumabe 2026-01-28T17:47:24+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/kesimpta/manejo-da-emr-com-kesimpta-apos-falha-terapeutica-com-terapia-de-reconstituicao-imune 2026-01-28T17:29:53+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/kesimpta/nenhuma-evidencia-de-atividade-da-doenca-neda-3-estas-avaliacoes-sao-importantes-para-os-pacientes 2026-01-19T18:58:04+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/kesimpta/kesimpta-ofatumumabe-faz-parte-do-rol-da-ans 2026-01-28T18:10:25+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/medicamentos/neurologia/kesimpta/explorando-os-diferentes-perfis-de-pacientes-em-tratamento-com 2025-11-10T20:37:31+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/kesimpta/highlights-do-evento-ms-forum-latam-2024 2026-01-19T19:09:39+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/kesimpta/highlights-do-evento-mscience-2025 2026-01-19T19:10:20+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/xolair/xolair-omalizumabe-na-urticaria-cronica-espontanea-uce 2026-01-28T19:07:38+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/xolair/omalizumabe-na-reversao-do-remodelamento-pulmonar-em-pacientes-com-asma-alergica-grave 2026-01-23T17:51:36+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/xolair/asma-e-uce-guia-de-prescricao-de-omalizumabe-xolair-para-profissionais-da-saude 2026-01-28T19:10:15+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/cosentyx/psoriase-mecanismos-da-epigenetica-e-o-estudo-stepin-dra-maria-vitoria-suarez-pt1 2026-01-22T19:49:05+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/cosentyx/psoriase-mecanismos-da-epigenetica-e-o-estudo-stepin-dra-maria-vitoria-suarez-pt2 2026-01-22T19:50:48+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/medicamentos/neurologia/kesimpta/kesimpta-esclerose-multipla 2025-11-10T19:46:43+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/medicamentos/oncologia/kisqali/beneficio-de-kisqalir-em-pacientes-idosas 2025-11-12T14:05:47+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kesimpta/ofatumumabe-mantem-seguranca-e-eficacia-em-emr-por-ate-7-anos 2026-01-19T19:13:59+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kesimpta/risco-de-infeccoes-graves-permaneceu-baixo-com-o-tratamento-de-longo-prazo 2026-01-19T19:14:33+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/kisqali/apoio-que-soma-sua-pratica-clinica-cancer-de-mama-materiais-para-pacientes 2026-01-19T20:03:21+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kisqali/podcast-reinovar-episodio-1-transformacao-digital 2026-01-19T19:51:21+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kisqali/podcast-reinovar-episodio-2-revolucao-digital-na-medicina 2026-01-19T19:52:47+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kisqali/podcast-reinovar-episodio-3-como-aplicar-transformacao-no-dia-dia 2026-01-19T19:53:25+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kisqali/o-programa-bem-estar-e-importancia-do-atendimento-nos-pilares-de-educacao-em-saude-e-adesao 2026-01-19T19:54:07+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kisqali/o-programa-bem-estar-e-importancia-do-atendimento-nos-pilares-de-acesso-e-adesao 2026-01-19T19:55:15+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kisqali/atualizacoes-das-diretrizes-abc-e-esmo-por-dr-carlos-barrios 2026-01-19T19:55:52+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kisqali/highlights-atualizacoes-das-diretrizes-abc-e-esmo-por-dr-carlos-barrios 2026-01-19T19:56:42+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kisqali/highlights-video-bem-estar-dra-maria-cristina 2026-01-19T19:58:59+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kisqali/highlights-video-bem-estar-dr-daniel-luiz 2026-01-19T20:00:15+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kisqali/evolucao-dos-testes-moleculares-na-oncologia-dra-ana-carolina-paniza-saude-digital 2026-01-19T20:00:57+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kisqali/jornada-digital-do-paciente-na-espanha-dra-karla-emerenciano-saude-digital 2026-01-19T20:01:40+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kisqali/jornada-digital-do-paciente-em-israel-dr-jorge-leal-saude-digital 2026-01-19T20:02:29+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kisqali/qual-importancia-de-balancear-sobrevida-global-livre-de-progressao-e-qualidade-de-vida-em-pacientes 2026-01-28T18:41:11+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/como-diretrizes-da-esmo-mcbs-influenciam-sua-abordagem-ao-tratamento-de-primeira-linha-em-pacientes 2025-11-10T19:07:11+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/sybrava/desafios-para-o-alcance-de-metas-do-colesterol-ldl-c1 2026-01-26T11:55:29+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kisqali/necessidades-nao-atendidas-no-cancer-de-mama-precoce-rhher2-asco-2025-dr-stephen-chia-canada 2026-01-28T18:37:11+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/kisqali/beneficio-e-dados-de-kisqali-em-pacientes-com-metastases-viscerais-e-doenca-agressiva 2026-01-28T18:29:22+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/sybrava/doencas-cardiovasculares-e-o-risco-do-ldl-c-nao-controlado-no-brasil 2026-01-23T17:57:13+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/sybrava/como-atingir-meta-para-o-controle-do-ldl-c-em-pacientes-de-muito-alto-risco12 2026-01-26T11:57:27+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/sybrava/recomendacoes-para-pacientes-com-muito-alto-risco-cardiovascular1 2026-01-26T11:59:47+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/sybrava/pacientes-que-ja-sofreram-iam-ou-avci-precisam-manter-seu-ldl-c 2026-01-26T12:01:10+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/sybrava/nova-era-no-controle-do-colesterol-ldl-traz-uma-mudanca-bem-vinda-para-medicos-e-pacientes1 2026-01-26T12:01:49+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/sybrava/cuidados-para-o-seu-paciente-de-muito-alto-risco1 2026-01-26T12:02:32+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/sybrava/mitos-sobre-o-ldl-c-e-como-superar-o-desafio-do-alcance-de-metas1 2026-01-26T12:03:12+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/sybrava/sybrava-pequeno-rna-de-interferencia-sirna1 2026-01-28T19:13:05+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/sybrava/doencas-cardiovasculares-e-o-risco-do-ldl-c-nao-controlado-no-brasil-dados-relevantes 2026-01-26T12:07:34+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/sybrava/chegada-de-novas-terapias-para-o-controle-do-colesterol-ldl12 2026-01-26T12:08:53+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/sybrava/importancia-do-controle-adequado-do-ldl-c1 2026-01-26T12:11:37+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/sybrava/evidencias-cientificas-sobre-o-controle-sustentado-do-ldl-c-e-seus-beneficios1-3 2026-01-26T12:12:21+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/sybrava/doencas-cardiovasculares-e-o-risco-do-ldl-c-nao-controlado-no-brasil-0 2026-01-26T12:12:55+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/sybrava/por-que-prevalencia-de-mortes-por-doencas-cardiovasculares-no-brasil-e-tao-grande1 2026-01-26T12:14:12+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/sybrava/enfrentando-os-desafios-do-alcance-das-metas-de-ldl-c1 2026-01-26T12:15:07+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/sybrava/inclisirana-primeiro-fortalecendo-estrategia-de-reducao-precoce-e-sustentada-do-ldl-c-com 2026-01-26T12:50:36+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/sybrava/estudo-komodo-adesao-ao-tratamento-de-dislipidemia-mista-com-inclisirana-caso-clinico-dr-bruno 2026-01-26T12:52:38+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/sybrava/pilulas-de-conteudo-com-o-dr-jose-rocha-faria-neto 2026-01-26T12:15:54+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kisqali/best-breast-discutindo-casos-clinicos-sobre-estudos-natalee-e-monarche-casos-1-e-2 2026-01-28T18:35:59+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kisqali/best-breast-discutindo-casos-clinicos-sobre-estudos-natalee-e-monarche-caso-3 2026-01-28T18:30:06+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/sybrava/estudo-orion-8-eficacia-e-seguranca-de-longo-prazo-da-inclisirana1 2026-01-26T12:49:31+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/sybrava/o-que-e-sybrava 2026-01-28T19:16:28+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/sybrava/mecanismo-de-acao-de-sybrava 2026-01-26T13:52:30+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/sybrava/sybrava-inclisirana-na-pratica-clinica 2026-02-23T15:19:05+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/sybrava/evidencias-de-sybrava-inclisirana 2026-01-28T19:25:00+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/sybrava/sybrava-inclisirana-reducao-do-ldl-c-em-pacientes-pos-infarto-agudo-do-miocardio-iam3 2026-01-28T19:15:37+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kisqali/papel-das-ferramentas-da-aga-em-pacientes-idosas-com-cancer-de-mama 2026-01-19T20:04:56+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kisqali/sobre-aga-avaliacao-geriatrica-ampla-em-pacientes-idosas-com-cancer-de-mama 2026-01-19T20:08:04+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/sybrava/o-desafio-da-intolerancia-estatinas 2026-01-26T13:55:37+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/pluvicto/mecanismo-de-acao-inovador-de-pluvicto 2026-01-26T16:28:48+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/conheca-o-programa-bem-estar-de-cancer-de-prostata 2025-11-14T11:52:43+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/programa-de-paciente-bem-estar-cancer-de-prostata-regulamento-do-servico-de-deslocamento-e 2025-11-14T14:11:59+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/conheca-o-servico-de-exame-pet-psma-no-tratamento-do-cancer-de-prostata-disponibilizado-pelo 2025-11-14T17:28:28+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/confira-o-passo-passo-para-solicitar-o-exame-pet-psma-oferecido-pelo-programa-bem-estar 2025-11-14T18:09:53+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/saiba-mais-sobre-o-suporte-em-deslocamento-aereo-e-hospedagem-para-o-paciente-de-pluvictor 2025-11-14T18:37:00+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/confira-o-passo-passo-para-solicitar-o-servico-de-deslocamento-e-hospedagem-para-pacientes-em 2025-11-17T20:11:51+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/esta-disponivel-para-comercializacao-tratamento-inovador-com-177lu-psma-617-para-cancer-de-prostata 2025-11-17T19:19:43+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/sequeciamento-do-paciente-com-cancer-de-prostata-resistente-castracao-com-dr-denis-jardim 2025-11-18T13:02:00+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/video/pluvicto/o-papel-do-medico-nuclear-na-jornada-do-paciente-com-cprcm-dra-leticia-rigo 2026-01-26T16:39:56+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/pluvicto/guia-pratico-de-tratamento-com-pluvicto 2026-01-29T00:24:44+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/pluvicto/qualidade-de-vida-do-paciente-com-cprcm-e-terapia-com-pluvicto 2026-01-26T16:42:51+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kisqali/ferramentas-de-triagem-da-aga-em-pacientes-idosas-com-cancer-de-mama 2026-01-19T20:09:18+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/pluvicto/dr-denis-jardim-apresenta-tratamento-inovador-com-177lu-psma-617-para-cancer-de-prostata-aprovado 2026-01-26T16:46:04+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/pluvicto/importancia-do-cuidado-multidisciplinar-alem-da-terapia-com-pluvicto-dr-jorge-garcia 2026-01-26T16:57:05+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/pluvicto/dr-fernando-maluf-fala-sobre-o-primeiro-paciente-de-pluvicto 2026-01-29T00:25:43+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/pluvicto/bem-estar-cancer-de-prostata-pluvicto-conheca-como-funciona-o-exame-pet-psma 2026-01-26T17:22:07+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/pluvicto/bem-estar-cancer-de-prostata-pluvicto-como-funciona-o-tratamento-com-pluvicto 2026-01-26T17:23:36+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/pluvicto/programa-de-paciente-bem-estar-cancer-de-prostata-materiais-para-pacientes 2026-01-26T17:26:20+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/pluvicto/evolucao-do-tratamento-na-trajetoria-do-paciente-e-terapia-com-pluvicto-dr-jorge-garcia-eua 2026-01-29T00:26:28+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/pluvicto/tipos-de-radiacao-e-impactos-no-tratamento-prostatalk-dr-marcelo-livorsi 2026-01-26T17:31:29+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/pluvicto/manejo-no-tratamento-do-cancer-de-prostata-rlt-insider-dr-marcelo-livorsi 2026-01-26T17:35:07+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/pluvicto/explicacao-teranosticos-prostatalk-dr-marcelo-livorsi 2026-01-26T17:39:29+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/pluvicto/relato-de-caso-com-o-dr-jorge-garcia-tratamento-de-paciente-com-cprcm-apos-progressao-arpi-e-taxano 2026-01-26T17:41:52+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/pluvicto/qualidade-de-vida-e-seguranca-no-tratamento-do-cancer-de-prostata-rlt-insider-dr-diogo-bastos-e-dr 2026-01-26T17:50:26+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/pluvicto/exames-para-diagnosticos-prostatalk-dr-marcelo-livorsi 2026-01-26T17:52:34+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/pluvicto/cuidados-com-paciente-prostatalk-dr-marcelo-livorsi 2026-01-26T18:04:11+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/pluvicto/ciclos-de-tratamento-e-acompanhamento-prostatalk-dr-marcelo-livorsi-e-dr-ariel-g-kann 2026-01-26T18:07:49+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/pluvicto/programa-bem-estar-conheca-os-servicos-para-pacientes-com-cancer-de-prostata-metastatico 2026-01-26T18:09:57+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/experiencias-expert-relevancia-de-pluvicto-no-tratamento-cprcm-caso-clinico-dr-pedro-barata-eua 2025-11-19T17:24:20+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/relato-de-caso-com-dr-pedro-barata-e-dr-eduardo-bischoff-terapia-de-paciente-com-cprcm-no-cenario 2025-11-19T17:44:34+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/conexao-entre-especialistas-acesso-aos-medicamentos-prostatalk-dr-ariel-g-kann-e-dr-marcelo-livorsi 2025-11-19T17:59:32+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/exames-para-diagnosticos-prostatalk-dr-ariel-g-kann 2025-11-19T18:04:09+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/entendendo-o-papel-da-epigenetica-na-patogenese-da-psoriase 2026-01-22T19:51:34+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/estudo-sculpture-5-anos-de-tratamento-com-secuquinumabe-em-pacientes-com-psoriase-em-placas 2026-01-22T19:53:00+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/psoriase-impacto-alem-da-pele 2026-01-22T19:55:41+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/tratando-psoriase-em-placas-de-moderada-grave-e-impacto-emocional-grave-quando-o-tratamento-topico 2026-01-22T19:54:06+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/relato-de-caso-abordagem-multidisciplinar-na-hidradenite-supurativa 2026-01-22T19:56:48+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/cosentyx-secuquinumabe-tratamento-completo 2026-01-28T19:01:10+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/cosentyx-para-psoriase-em-areas-especiais 2026-01-28T19:01:47+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/panlar-2025-desafios-no-tratamento-da-artrite-psoriasica-dra-mariana-peixoto 2026-01-23T13:04:55+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/panlar-2025-insights-sobre-espondiloartrites-e-artrite-psoriasica-dr-gustavo-guimaraes 2025-11-26T16:34:10+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/cosentyx/espondiloartrite-e-suas-classificacoes-panlar-2025-dra-mariana-peixoto 2026-01-22T20:02:04+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/cosentyx/expectativa-de-vida-e-espondiloartrite-panlar-2025-dr-gustavo-resende 2026-01-22T20:02:58+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/cosentyx-da-resposta-clinica-reversao-molecular 2026-01-28T19:02:33+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/medicamentos/oncologia/kisqali/sobrevida-global-de-ate-5-anos-com-kisqali 2025-12-03T19:27:45+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kisqali/atualizacao-natalee-5-anos-dr-carlos-barrios 2026-01-19T20:10:48+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kisqali/tratamento-cmm-em-paciente-idosa-no-sus-caso-clinico-dra-marcia-figueiredo 2026-01-19T20:12:59+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kesimpta/manejo-da-seguranca-na-emrr-dra-samira-apostolos 2026-01-19T19:15:22+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/ultrassonografia-no-diagnostico-da-artrite-psoriasica-uma-aliada-na-pratica-clinica-e-na-jornada 2026-01-23T13:08:26+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/cosentyx-na-prevencao-da-progressao-radiografica-evidencia-clinica-para-protecao-estrutural-em 2026-01-28T19:03:23+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/fabhalta/entendendo-hpn-hemoglobinuria-paroxistica-noturna 2026-01-26T20:21:19+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/fabhalta/mecanismo-de-acao-na-hpn 2026-01-26T20:22:00+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/fabhalta/o-impacto-da-hpn 2026-01-26T20:22:35+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/cosentyx-em-pacientes-com-artrite-psoriasica-e-doenca-axial 2026-01-28T19:04:30+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/fabhalta/resumo-da-hpn 2026-01-26T20:23:14+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/fabhalta/fabhalta-e-aprovado-pela-anvisa 2026-01-27T16:06:43+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/fabhalta/necessidades-remanescentes-nao-atendidas-e-o-novo-tratamento-com-fabhalta-para-hpn-hemoglobinuria 2026-01-27T16:07:02+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/fabhalta/saiba-mais-sobre-o-tratamento-de-pacientes-com-hpn 2026-01-27T12:48:27+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/fabhalta/saiba-mais-sobre-o-apply1-um-dos-estudos-pivotais-que-embasou-aprovacao-de-fabhalta-cloridrato-de 2026-01-27T17:17:51+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/fabhalta/arena-hpn-no-hemo-2024-highlights-com-ana-beatriz-de-almeida-iqvia-parte-1 2026-01-27T12:55:07+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/fabhalta/arena-hpn-no-hemo-2024-highlights-com-nina-melo-abrale-parte-2 2026-01-27T12:58:26+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/fabhalta/arena-hpn-no-hemo-2024-highlights-com-gustavo-san-martin-cronicos-do-dia-dia-e-dr-rodolfo-cancado 2026-01-27T13:04:55+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/fabhalta/cafe-com-especialista-hpn-no-hemo-2024-dr-diego-cle-crm-16340-sp-parte-1 2026-01-27T13:14:33+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/fabhalta/cafe-com-especialista-hpn-no-hemo-2024-dra-paula-campos-crm-129553-sp-parte-2 2026-01-27T13:17:50+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/fabhalta/video-com-o-dr-rodolfo-cancado-sobre-o-estudo-apply 2026-01-27T13:22:22+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/fabhalta/fabhalta-e-a-primeira-e-unica-monoterapia-oral-para-hpn-que-permite-a-tripla-normalizacao-hb-ldh-e-qdv 2026-01-27T16:05:34+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/fabhalta/hemo-highlights-arena-hpn 2026-01-27T13:22:45+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/fabhalta/fadiga-um-problema-nao-resolvido-em-pacientes-com-hpn 2026-01-27T16:04:57+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/fabhalta/hemo-highlights-cafe-com-especialista-hpn 2026-01-27T13:34:32+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/fabhalta/highlights-do-congresso-hemo-2024 2026-01-27T13:38:05+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/fabhalta/controle-incompleto-da-hemolise-desafio-ainda-a-ser-vencido 2026-01-27T16:04:07+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/fabhalta/conheca-mais-sobre-o-appoint1-um-dos-estudos-pivotais-que-embasou-aprovacao-de-fabhalta-cloridrato 2026-01-27T17:20:23+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/fabhalta/estudo-appoint-um-dos-estudos-pivotais-que-embasou-aprovacao-do-fabhalta-dr-rodolfo-cancado 2026-01-27T17:21:33+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/fabhalta/fabhalta-cloridrato-de-iptacopana-e-bem-tolerado-e-tem-perfil-de-seguranca-bem-estabelecido1 2026-01-27T17:25:16+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/scemblix/expert-talks-o-estudo-ascembl-no-tratamento-da-lmc-dr-michael-j-mauro-eua 2026-02-10T14:33:21+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/scemblix/expert-talks-inicio-de-estudo-ascembl-caso-clinico-switch-de-tratamento-dr-michael-j-mauro 2026-01-27T17:55:20+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/scemblix/expert-talks-inicio-de-estudo-x2101-phase-1-dr-michael-j-mauro-eua 2026-01-27T18:00:27+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/scemblix/tolerabilidade-sinalizando-mudancas-na-lmc-perspectiva-do-painel-de-especialistas 2026-01-27T18:11:13+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/scemblix/resposta-abaixo-do-ideal-sinalizando-mudancas-na-lmc-perspectiva-do-painel-de-especialistas 2026-01-27T18:12:47+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/scemblix/por-que-escolher-asciminibe-no-tratamento-da-lmc-sinalizando-mudancas-na-lmc-perspectiva-do-painel 2026-01-27T18:14:06+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/scemblix/consideracoes-sobre-novo-tratamento-ou-ajuste-de-dose-sinalizando-mudancas-na-lmc-perspectiva-do 2026-01-27T18:15:21+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/scemblix/sinalizando-mudanca-na-lmc 2026-01-27T18:29:27+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/scemblix/tratamento-de-lmc-risco-intermediario-na-escala-tls-caso-clinico-dr-fabio-pires 2026-01-27T18:35:54+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/scemblix/estudo-ascafirst-em-pacientes-com-lmc-para-cromossomo-filadelfia 2026-01-27T18:37:35+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/scemblix/carenapp-evolucao-na-jornada-do-paciente-hematologico 2026-02-10T14:48:13+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/cosentyx/conexoes-da-psa-com-outras-especialidades-psiquiatria-drluiz-dieckmann 2026-01-23T13:12:18+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/scemblix/tratamento-de-lmc-em-paciente-de-65-anos-caso-clinico-dr-fabio-nucci 2026-01-27T18:40:05+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/scemblix/video-evento-one-scemblix-estudo-cml-sun-dra-carla-boquimpani 2026-01-27T18:41:00+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/scemblix/video-evento-one-scemblix-historia-da-lmc-dra-samila-santana 2026-01-27T18:42:01+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/jakavi/hemo-highlights-cafe-com-especialista-mielofibrose 2026-01-28T13:05:52+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/jakavi/tratamento-da-mielofibrose-quanto-antes-melhor-beneficios-do-tratamento-precoce-da-mielofibrose 2026-01-28T13:08:02+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/jakavi/importancia-da-conscientizacao-sobre-mielofibrose 2026-01-28T13:11:03+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/jakavi/introducao-mielofibrose 2026-01-28T13:16:27+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/jakavi/conheca-jakavi-ruxolitinibe-tratamento-indicado-para-mielofibrose-mf-policitemia-vera-pv-e-doenca 2026-01-28T13:17:09+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/jakavi/sintomas-da-mf-alto-impacto-na-vida-dos-pacientes1-5 2026-01-28T13:22:15+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/jakavi/conheca-mais-sobre-policitemia-vera-pv 2026-01-28T13:23:00+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/jakavi/tratamento-da-mielofibrose-mf 2026-01-28T13:26:10+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/jakavi/diagnostico-diferencial-da-mielofibrose-mf123 2026-01-28T13:31:13+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/jakavi/forum-cientifico-mpn-summit-para-neoplasias-mieloproliferativas 2026-01-28T13:35:51+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/analises-estrategicas-na-esclerose-multipla-moderna-tratamento-resultados-e-seguranca-do-ofatumumab 2026-01-21T13:05:50+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/formulario-pest 2026-03-25T14:02:32+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/pluvicto/relevancia-do-uso-do-pluvicto-no-tratamento-de-pacientes-com-cprcm-dr-diogo-rosa-e-dra-gisele 2026-01-26T19:59:26+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/pluvicto/video-rlt-insider-salvador-dr-augusto-mota-e-dra-adelina-sanches 2026-01-26T20:07:39+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/entresto/diferencas-fisiopatologicas-de-genero-na-insuficiencia-cardiaca 2026-02-13T13:35:51+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/entresto/teaser-dr-humberto-villacorta-caso-clinico-nt-probnp-no-diagnostico-e-monitoramento-do-paciente-com 2026-01-28T14:25:13+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/entresto/caso-clinico-desmistificando-o-diagnostico-da-icfep-dr-luiz-c-danzmann 2026-01-28T14:37:15+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/il-17i-nas-6-manifestacoes-da-artrite-psoriasica-aps 2026-01-28T19:42:05+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/kisqali/desfechos-de-5-anos-do-estudo-natalee 2026-02-02T13:15:41+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kisqali/esmo-2025-perspectiva-sobre-necessidade-nao-atendidas-para-pacientes-de-cancer-de-mama-dr-carlos-barrios 2026-02-03T12:07:55+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/tratando-psoriase-em-placas-de-moderada-grave-e-impacto-emocional-grave-o-seu-paciente-esta-com-o-tratamento-ideal 2026-02-11T13:27:14+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/seguranca-de-secuquinumabe-vs-anti-tnf 2026-02-11T13:42:35+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/fabhalta/caso-clinico-glomerulopatia-por-c3 2026-02-24T10:40:19+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/fabhalta/glomerulonefrite-por-c3-recorrencia-pos-transplante-renal 2026-02-24T10:39:14+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/ultrassonografia-no-diagnostico-da-artrite-psoriasica-uma-aliada-na-pratica-clinica-e-na-jornada- 2026-03-11T14:01:53+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/ressonancia-magnetica-das-articulacoes-na-artrite-psoriasica 2026-03-11T14:01:33+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/cosentyx/janela-de-oportunidade-na-hidradenite-supurativa-por-que-o-diagnostico-e-o-estadiamento-precoces 2026-03-26T18:13:38+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/pluvicto/gestao-do-medicamento-pluvicto-center-excellence-dr-david-kersting-e-dr-alex-moraitis 2026-03-12T11:21:44+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/pluvicto/layout-e-projeto-da-area-de-tratamento-pluvicto-center-excellence-dr-alex-moraitis 2026-03-12T11:04:23+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/pluvicto/colaboracao-da-equipe-multidisciplinar-pluvicto-center-excellence-prof-ken-herrman 2026-03-12T11:24:26+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/pluvicto/programa-de-seguranca-radiologica-pluvicto-center-excellence-dr-pedro-fragoso-costa 2026-03-12T11:17:54+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/artigos/consentyx/e-possivel-reduzir-progressao-radiografica-na-artrite-psoriasica 2026-03-16T11:57:02+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/pluvicto/onboarding-centro-de-tratamento-pluvicto-gianina-venturin 2026-03-17T18:09:04+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/revolade/tratamento-e-manejo-de-pti-com-doenca-associada-caso-clinico-dra-andrea-soares 2026-03-18T14:48:11+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/relovade/importancia-do-tratamento-individualizado-caso-clinico-sobre-pti-dra-andrea-garcia 2026-03-18T14:26:51+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/controle-dos-sintomas-para-seu-paciente-desde-infancia-ate-vida-adulta 2026-03-18T17:08:47+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/kisqali/one-kisqali-da-adjuvancia-ao-avancado-speaker-training-dr-jorge-leal-e-dr-ruffo-freitas 2026-03-26T13:01:57+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/pluvicto/experiencias-de-experts-caso-clinico-cprcm-dr-augusto-mota-e-dra-adelina-sanches 2026-04-01T17:05:13+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/cosentyx/hidradenite-supurativa-e-estudo-sunny-speaker-training-dr-gleison-duarte 2026-04-02T11:16:39+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/scemblix/dr-dennis-kim-compartilha-insights-essenciais-sobre-o-manejo-atual-da-lmc-dr-dennis-kim-canada 2026-04-01T18:59:38+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/videos/scemblix/evolucao-do-tratamento-da-lmc-dr-jorge-cortes-eua 2026-04-01T19:36:05+00:00 hourly 0.5 https://www.pro.novartis.com/br-pt/eventos/kisqali/novidades-para-celebrar-20260425 2026-03-26T12:07:36+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/eventos/kisqali/novidades-para-celebrar-20260411 2026-03-31T17:44:24+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/eventos 2026-02-03T13:55:53+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/conteudo 2025-12-08T13:14:01+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/medicamentos 2025-10-21T12:44:48+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/termos-de-uso 2025-10-23T17:13:30+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/aviso-de-privacidade 2026-03-12T14:17:43+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/inicio 2026-01-28T13:26:12+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/medicamentos/dermatologia 2025-10-22T19:41:34+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/medicamentos/reumatologia 2025-10-22T19:46:21+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/acessibilidade 2025-10-22T19:35:59+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/contato 2025-10-22T18:54:42+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/kisqali 2026-02-24T13:27:37+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/kesimpta 2026-02-19T17:14:33+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas 2025-12-08T18:48:18+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas-area-terapeutica 2025-12-08T18:48:00+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/xolair 2026-01-05T18:13:37+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/cosentyx 2026-01-05T18:14:44+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/sybrava 2026-01-05T18:19:45+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/pluvicto 2026-01-05T18:14:12+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/entresto 2026-01-05T18:15:08+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/jakavi 2026-02-13T15:26:20+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/scemblix 2026-02-05T20:55:11+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/fabhalta 2026-01-05T18:15:44+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/tegretol 2026-01-05T18:20:48+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/estudos-clinicos 2025-12-12T12:27:17+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/produtos-descontinuados 2026-02-03T12:54:47+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/voce-no-controle-das-suas-preferencias-de-comunicacao 2026-01-15T14:29:55+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/medicamentos/oncologia 2026-02-25T21:20:12+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/medicamentos/hematologia 2026-02-25T21:08:08+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/medicamentos/neurologia 2026-02-25T21:23:37+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/medicamentos/cardiologia 2026-02-25T21:01:40+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/medicamentos/imunologia 2026-02-25T21:04:42+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/cosentyx 2026-02-10T18:56:39+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/medicamentos/dermatologia/xolair 2025-12-16T13:32:18+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/medicamentos/neurologia/kesimpta 2025-11-26T17:37:06+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/medicamentos/oncologia/kisqali 2026-02-02T14:11:55+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/medicamentos/cardiologia/sybrava 2026-02-23T14:54:26+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/medicamentos/cardiologia/entresto 2026-02-10T19:04:56+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/medicamentos/oncologia/pluvicto 2026-02-25T13:06:24+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/vigamox 2026-03-03T19:02:03+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/diovan-hct 2026-02-12T12:27:42+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/medicamentos/hematologia/fabhalta 2026-02-05T14:32:04+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/galvus 2026-02-12T00:06:29+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/medicamentos/hematologia/jakavi 2026-01-28T17:58:35+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/maxidex 2026-02-19T20:00:40+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/mekinist 2026-02-20T13:06:57+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/revolade 2026-02-25T13:37:03+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/ritalina 2026-02-25T15:03:07+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/medicamentos/hematologia/scemblix 2026-03-02T20:35:05+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/tafinlar 2026-02-27T17:43:28+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/tegretol 2025-11-26T19:25:52+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/trileptal 2026-03-02T17:19:36+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/voltaren 2026-03-03T19:23:06+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/zolgensma 2026-02-23T13:20:29+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/aciclovir 2026-02-10T17:13:51+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/afinitor 2026-02-09T18:25:44+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/alendronato-de-sodio 2026-02-09T18:26:56+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/alopurinol 2026-02-09T18:27:29+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/amoxicilina-clavulanato-de-potassio 2026-02-09T18:28:08+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/anestalcon 2026-02-09T18:43:13+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/aripiprazol 2026-02-09T18:28:42+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/atorvastatina-calcica 2026-02-09T19:35:59+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/azopt 2026-02-09T18:45:11+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/azorga 2026-02-09T18:46:06+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/besilato-de-anlodipino 2026-02-09T18:46:59+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/bissulfato-de-clopidogrel 2026-02-09T18:48:02+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/cataflam 2026-02-09T19:17:30+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/certican 2026-02-09T19:21:06+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/cerumin 2026-02-09T19:21:42+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/cilodex 2026-02-09T19:22:04+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/ciloxan 2026-02-09T19:25:13+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/claril 2026-02-09T19:26:23+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/claroft 2026-02-09T19:32:42+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/cloridrato-de-ciprofloxacino 2026-02-09T19:33:47+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/cloridrato-de-donepezila 2026-02-10T12:34:01+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/cloridrato-de-fluoxetina 2026-02-10T18:55:11+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/cloridrato-de-memantina 2026-02-10T14:15:50+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/desogestrel 2026-02-10T19:15:23+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/diovan-amlo-fix 2026-02-10T19:30:52+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/diovan 2026-02-10T19:28:53+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/exforge-hct 2026-02-10T19:42:25+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/exjade 2026-02-11T12:58:03+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/femara 2026-02-11T17:30:50+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/flotac 2026-02-11T17:58:33+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/galvus-met 2026-02-11T18:17:19+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/gilenya 2026-02-12T15:11:37+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/glivec 2026-02-12T19:19:10+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/hemifumarato-de-quetiapina 2026-02-13T15:30:28+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/hemitartarato-de-zolpidem 2026-02-13T16:55:13+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/ilaris 2026-02-13T17:02:23+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/kiendra 2026-02-19T16:58:00+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/kymriah 2026-02-19T17:05:03+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/levofloxacino 2026-02-19T17:12:17+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/lucentis 2026-02-19T17:26:31+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/luxturna 2026-03-16T19:03:59+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/maxitrol 2026-02-20T13:13:01+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/mesilato-de-doxazosina 2026-02-20T13:57:14+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/mirtazapina 2026-02-23T13:31:38+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/mydriacyl 2026-02-24T14:13:00+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/myfortic 2026-02-24T18:15:26+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/nevanac 2026-02-25T18:53:06+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/onbrize 2026-02-25T11:49:39+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/oxalato-de-escitalopram 2026-02-25T12:17:07+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/pantoprazol 2026-02-25T12:47:41+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/patanol 2026-02-25T12:56:10+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/piqray 2026-02-25T13:02:37+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/risperidona 2026-02-25T18:33:22+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/rosuvastatina-calcica 2026-02-25T18:20:19+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/rydapt 2026-02-25T18:54:36+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/sandimmun 2026-02-26T12:03:06+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/sandostatin 2026-02-26T13:50:41+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/seebri 2026-02-26T14:36:26+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/simbrinza 2026-02-26T18:12:57+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/simulect 2026-02-26T18:32:01+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/sinvastatina 2026-02-26T18:50:50+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/tabrecta 2026-02-27T13:11:04+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/tasigna 2026-02-27T17:53:21+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/tobradex 2026-02-27T17:59:37+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/tobramicina-03-e-dexametasona-01 2026-02-27T18:09:21+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/tobrex 2026-03-02T17:12:59+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/travatan 2026-03-02T17:24:43+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/tykerb 2026-03-02T18:38:24+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/ultibro 2026-03-03T17:10:47+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/vigadexa 2026-03-12T20:00:03+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/votrient 2026-03-16T17:53:35+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/vsiqq 2026-03-16T18:42:28+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/bulas/zometa 2026-03-16T18:58:29+00:00 daily 0.5 https://www.pro.novartis.com/br-pt/sitemap.xml 2026-04-02T01:42:18+00:00